Morita, Mitsunori http://orcid.org/0000-0003-3083-4519
Tamiya, Motohiro
Fujimoto, Daichi
Tamiya, Akihiro
Suzuki, Hidekazu
Hirano, Katsuya
Fukuda, Yasushi
Yokoyama, Toshihide
Kominami, Ryota
Kanazu, Masaki
Uchida, Junji
Hara, Satoshi
Yamashita, Shuji
Tomioka, Hiromi
Article History
Received: 29 September 2019
Accepted: 27 January 2020
First Online: 3 February 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This retrospective study was approved by the Institutional Review Board in Osaka International Cancer Institute (approval No.1802199367) and each institution (Additional file InternalRef removed). For this type of study, formal consent is not required.
: Not applicable.
: Drs. M.Tamiya, A.Tamiya, Fujimoto, and Hirano have received lecture fees from Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan) and Merck Sharp & Dohme, Corp. (Tokyo, Japan). Drs. Yokoyama has received lecture fees from Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan). Drs. Kanazu has received lecture fees from Merck Sharp & Dohme, Corp. (Tokyo, Japan). The remaining authors have no conflicts of interest to declare.